Literature DB >> 3129477

Lung extravascular volume during venovenous bypass with extracorporeal CO2-removal in dogs.

J Peters1, P Radermacher, U Lenhsen, B Lohe, P Rösen, K J Falke.   

Abstract

Extracorporeal circulation can cause lung damage, which would be especially counterproductive during extracorporeal gas exchange for the treatment of acute respiratory failure. To test the hypothesis that partial venovenous bypass with extracorporeal CO2-removal combined with low-frequency positive pressure ventilation (ECCO2R-LFPPV) can adversely affect lung fluid balance, extravascular thermal lung volume (ETV) and hemodynamics were assessed before, during and after ECCO2R-LFPPV in normal closed chest dogs. In series I dogs (n = 6) subjected to 10 h of ECCO2R-LFPPV, ETV did not change significantly from control (7.1 ml/kg +/- 0.99 SE) during or after bypass. Gravimetric extravascular lung water and lung histology after bypass were found to be normal. In series II dogs (n = 5), subjected to shorter periods of ECCO2R-LFPPV, ETV also remained unchanged. In contrast to previous reports using sheep, pulmonary arterial hypertension during bypass was not observed. Thus, ECCO2R-LFPPV was not associated with increased lung water, pulmonary hypertension or morphological lung changes under the conditions studied and does not seem to cause lung damage in normal lungs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129477     DOI: 10.1007/bf00257465

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  Thermal-dye lung water measurements: effects of edema and embolization.

Authors:  L Oppenheimer; V B Elings; F R Lewis
Journal:  J Surg Res       Date:  1979-05       Impact factor: 2.192

Review 2.  Pulmonary edema.

Authors:  N C Staub
Journal:  Physiol Rev       Date:  1974-07       Impact factor: 37.312

3.  Partial cardiopulmonary bypass lasting up to seven days in alert lambs with membrane lung blood oxygenation.

Authors:  T Kolobow; W M Zapol; R L Sigman; J Pierce
Journal:  J Thorac Cardiovasc Surg       Date:  1970-12       Impact factor: 5.209

4.  The corrected protein equation to estimate plasma colloid osmotic pressure and its development on a nomogram.

Authors:  S Nitta; T Ohnuki; K Ohkuda; T Nakada; N C Staub
Journal:  Tohoku J Exp Med       Date:  1981-09       Impact factor: 1.848

5.  Venous air emboli in sheep: reversible increase in lung microvascular permeability.

Authors:  K Ohkuda; K Nakahara; A Binder; N C Staub
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-10

6.  Control of breathing using an extracorporeal membrane lung.

Authors:  T Kolobow; L Gattinoni; T A Tomlinson; J E Pierce
Journal:  Anesthesiology       Date:  1977-02       Impact factor: 7.892

7.  Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep.

Authors:  A J Erdmann; T R Vaughan; K L Brigham; W C Woolverton; N C Staub
Journal:  Circ Res       Date:  1975-09       Impact factor: 17.367

8.  Tracheal and alveolar gas composition during low-frequency positive pressure ventilation with extracorporeal CO2-removal (LFPPV-ECCO2R).

Authors:  J Peters; P Radermacher; A Pesenti; H D Schulte; K J Falke
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

9.  Effect of positive end-expiratory pressure on lung water in pulmonary edema caused by increased membrane permeability.

Authors:  C Helbert; A Paskanik; C E Bredenberg
Journal:  Ann Thorac Surg       Date:  1983-07       Impact factor: 4.330

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  1 in total

1.  Extracorporeal CO2-removal with a heparin coated artificial lung.

Authors:  J Peters; P Radermacher; M E Kuntz; K A Rosenbauer; M Breulmann; K F Bürrig; H B Hopf; R Rossaint; H D Schulte; P Olsson
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.